D-peptides as immunogens and diagnostic reagents

Current Opinion in Biotechnology

Volumn 9, Issue 4, 1998, Pages 377-382

  Van Regenmortel, Marc H V ^a   Muller, Sylviane ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DEXTRO AMINO ACID; DIAGNOSTIC AGENT; IMMUNOMODULATING AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; VACCINE;

IMMUNOMODULATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; T LYMPHOCYTE ACTIVATION;

ANIMALIA; FOOT-AND-MOUTH DISEASE VIRUS;

EID: 0032145395     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(98)80011-6     Document Type: Article

References (37)

1. Milton De RCL, Milton SCF, Kent SBH. Total chemical synthesis of a D-enzyme: the enantiomers of HIV-1 protease show demonstration of reciprocal chiral substrate specificity. Science. 256:1992;1445-1448.
2. Sela M, Zisman E. Different roles of D-amino acids in immune phenomena. FASEB J. 11:1997;449-456.
3. Dintzis HM, Symer DE, Dintzis RZ, Zawadzke LE, Berg JM. A comparison of the immunogenecity of a pair of enantiomeric proteins. Proteins. 16:1993;306-308.
4. Benkirane N, Friede M, Guichard G, Briand JP, Van Regenmortel MHV, Muller S. Antigenicity and immunogenicity of modified synthetic peptides containing D-amino acid residues. J Biol Chem. 268:1993;26279-26285.
5. Thérien HM, Shahum E, Fortin A. Liposome adjuvanticity: influence of dose and protein:lipid ratio on the humoral response to encapsulated and surface-linked antigen. Cell Immunol. 136:1991;402-413.
6. Glenn GM, Rao M, Richards RL, Matyas GR, Alving CR. Murine IgG subclass antibodies to antigens incorporated in liposomes containing lipid A. Immunol Lett. 47:1995;73-78.
7. Goodman M, Chorev M. On the concept of linear modified retropeptide structures. Accounts Chem Res. 12:1979;1-7.
8. Chorev M, Goodman M. Recent developments in retro peptides and proteins - an ongoing topochemical exploration. Trends Biotechnol. 13:1995;438-445.
9. Guichard G, Benkirane N, Zeder-Lutz G, Van Regenmortel MHV, Briand JP, Muller S. Antigenic mimicry of natural L-peptides with retro-inverso-peptidomimetics. Proc Natl Acad Sci USA. 91:1994;9765-9769.
10. Briand JP, Guichard G, Dumortier H, Muller S. Retro-inverso peptidomimetics as new immunological probes. J Biol Chem. 270:1995;20686-20691.
11. Verdoliva A, Ruvo M, Cassani G, Fassina G. Topological mimicry of cross-reacting enantiomeric peptide antigens. J Biol Chem. 270:1995;30422-30427.
12. Muller S, Guichard G, Benkirane N, Brown F, Van Regenmortel MHV, Briand JP. Enhanced immunogenicity and cross-reactivity of retro-inverso peptidomimetics of the major antigenic site of foot-and-mouth disease virus. Peptide Res. 8:1995;138-144.
13. Briand JP, Benkirane N, Guichard G, Newman JFE, Van Regenmortel MHV, Brown F, Muller S. A retro-inverso peptide corresponding to the GH loop of foot-and-mouth disease virus elicits high levels of long lasting protective neutralizing antibodies. Proc Natl Acad Sci USA. 94:1997;12545-12550.
14. Van Regenmortel MHV. Immunochemical recognition of retro-inverso peptides and their potential as synthetic vaccines. Brown F, Burton D, Doherty P, Mekalanos J, Norrby E. Molecular Approaches to the Control of Infectious Diseases - Vaccines 97. 1997;9-15 Cold Spring Harbor Laboratory Press, New York.
15. Guptasarma P. Symmetry transformations at α-carbons. Trends Biotechnol. 14:1996;42-43.
16. Chorev M, Goodman M. Symmetry transformations at α-carbons: reply. Trends Biotechnol. 14:1996;43-44.
17. Guichard G, Muller S, Van Regenmortel MHV, Briand JP, Mascagni P, Giralt E. Structural limitations to antigenic mimicry achievable with retro-inverso (all-D-retro) peptides. Trends Biotechnol. 14:1996;44-45.
18. Carver JA, Esposito G, Viglino P, Fogolari F, Guichard G, Briand JP, Van Regenmortel MHV, Brown F, Mascagni P. Structural comparison between retro-inverso and parent peptides. Molecular basis for the biological activity of a retro-inverso analogue of the immunodominant fragment of VP1 coat protein from foot-and-mouth disease virus. Biopolymers. 41:1997;569-590.
19. Benkirane N, Guichard G, Van Regenmortel MHV, Briand JP, Muller S. Cross-reactivity of antibodies to retro-inverso peptidomimetics with the parent protein histone H3 and chromatin core particle. Specificity and kinetic rate constant measurements. J Biol Chem. 270:1995;11921-11926.
20. Brown F. Foot-and-mouth Disease. Nicholson B. Synthetic Vaccines. 1994;416-432 Blackwell, Oxford.
21. Benkirane N, Guichard G, Briand JP, Muller S, Brown F, Van Regenmortel MHV. Mimicry of viral epitopes with retro-inverso peptides of increased stability. Brown F. Developments in Biol Standardization. 87:1996;281-289 Korger, Basel.
22. Muller S, Briand JP, Benkirane N, Guichard G, Van Regenmortel MHV, Newman JFE, Brown F. Antigenic mimicry with an all-D-retro peptide corresponding to the immunodominant loop of foot-and-mouth disease virus. Brown F, Burton D, Doherty P, Mekalanos J, Norrby E. Molecular Approaches to the Control of Infectious Diseases - Vaccines 97. 1997;17-22 Cold Spring Harbor Laboratory Press.
23. Briand JP, Muller S, Guichard G, Van Regenmortel MHV, Newman JFE, Brown F. Identification of a neutralizing decapeptide epitope on foot-and-mouth disease virus. Brown F, Burton D, Doherty P, Mekalanos J, Norrby E. Molecular Approaches to the Control of Infectious Diseases - Vaccines 97. 1997;23-26 Cold Spring Harbor Laboratory Press.
24. Hill MC, Liu A, Marshall KW, Mayer J, Jorgensen B, Yuan B, Cubbon RM, Nichols EA, Wicker L, Rothbard JB. Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401. J Immunol. 152:1994;2890-2898.
25. Hervé M, Maillère B, Mourier G, Texier C, Leroy S, Ménez A. On the immunogenic properties of retro-inverso peptides. Total retro-inverso of T-cell epitopes causes a loss of binding to MHC II molecules. Mol Immunol. 34:1997;157-163.
26. Maillère B, Mourier G, Cotton J, Hervé M, Leroy S, Ménez A. Probing immunogenicity of a T-cell epitope by L-alanine and D-amino acid scanning. Mol Immunol. 32:1995;1073-1080.
27. + T-cell clone. Eur J Immunol. 27:1997;1387-1391.
28. Mézière C, Viguier M, Dumortier H, Lo-Man R, Leclerc C, Guillet JG, Briand JP, Muller S. In vivo T helper cell response to retro-inverso peptidomimetics. J Immunol. 159:1997;3230-3237.
29. Saito NG, Paterson Y. Contribution of peptide backbone atoms to binding of an antigenic peptide to class I major histocompatibility complex molecule. Mol Immunol. 34:1997;1133-1145.
30. Zisman E, Dayan M, Sela M, Mozes E. Ia-antigen-T-cell interactions for a thymus-independent antigen. Proc Natl Acad Sci USA. 90:1993;994-998.
31. Schlegel PG, Aharoni R, Chen Y, Chen J, Teitelbaum D, Arnon R, Sela M, Chao NH. A synthetic random basic copolymer with promisucous binding to class II major histocompatibility complex molecules inhibits T-cell proliferative responses to major and minor histocompatibility antigens in vitro and confers the capacity to prevent murine graft-versus-host disease in vivo. Proc Natl Acad Sci USA. 93:1996;5061-5066.
32. Aharoni R, Schlegel PG, Teitelbaum D, Roikhel-Karpov O, Chen Y, Arnon R, Sela M, Chao NJ. Studies on the mechanism and specificity of the effect of the synthetic random copolymer GLAT on graft-versus-host disease. Immunol Lett. 58:1997;79-87.
33. Negri A, Ceciliani F, Tedeschi G, Simonic T, Ronchi S. The primary structure of the flavoprotein D-aspartate oxidase from beef kidney. J Biol Chem. 267:1992;11865-11871.
34. Vanoni MA, Cosma A, Mazzeo D, Mattevi A, Todone F, Curti B. Limited proteolysis and X-ray crystallography reveal the origin of substrate specificity and the rate-limiting product release during oxidation of D-amino acids catalyzed by mammalian D-amino acid oxidase. Biochemistry. 36:1997;5624-5632.
35. Grommé M, van der Valk R, Sliedregt K, Vernie L, Liskamp R, Hämmerling G, Koopman J-O, Momburg F, Neefjes J. The rational design of TAP inhibitors using peptide substrate modifications and peptidomimetics. Eur J Immunol. 27:1997;898-904.
36. McDonnel JM, Beavil AJ, Mackay GA, Jameson BA, Korngold R, Gould HJ, Sutton BJ. Structure based design and characterization of peptides that inhibit IgE binding to its high-affinity receptor. Nat Struct Biol. 3:1996;419-426.
37. Van Regenmortel MHV. Transcending the structuralist paradigm in immunology. Affinity and biological activity rather than purely structural considerations should guide the design of synthetic peptide epitopes. Biomed Pept Prot Nucleic Acids. 1:1995;109-116.